Jian-Zeng Dong Selected Research

Cardiac Tamponade

1/2022	Direct autotransfusion in the management of acute pericardial tamponade during catheter ablation for atrial fibrillation: An imperfect but practical method.
11/2021	A strategy of idarucizumab for pericardial tamponade during perioperative period of atrial fibrillation ablation.
4/2010	Autotransfusion in the management of cardiac tamponade occurring during catheter ablation of atrial fibrillation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jian-Zeng Dong Research Topics

Disease

81	Atrial Fibrillation 01/2024 - 01/2007
15	Stroke (Strokes) 10/2023 - 03/2013
12	Tachycardia (Tachyarrhythmias) 01/2023 - 04/2010
8	Heart Failure 01/2022 - 11/2013
6	Ischemic Stroke 01/2022 - 03/2013
6	Cardiac Arrhythmias (Arrythmia) 12/2019 - 01/2007
5	Thromboembolism 04/2022 - 01/2016
5	Thrombosis (Thrombus) 01/2022 - 12/2009
5	Myocardial Infarction 01/2022 - 12/2010
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 03/2009
4	Insulin Resistance 08/2023 - 10/2019
3	Death (Near-Death Experience) 10/2023 - 04/2017
3	Cardiac Tamponade 01/2022 - 04/2010
3	Hemorrhage 01/2022 - 12/2020
3	Infections 01/2022 - 10/2019
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2021
3	Hypertension (High Blood Pressure) 01/2021 - 10/2015
3	Inflammation (Inflammations) 10/2019 - 01/2018
3	Coronary Disease (Coronary Heart Disease) 01/2018 - 07/2010
3	Rheumatoid Arthritis 10/2015 - 01/2014
2	Autoimmune Diseases (Autoimmune Disease) 07/2023 - 10/2020
2	Takayasu Arteritis (Arteritis, Takayasu's) 01/2023 - 10/2020
2	Hyperinsulinism (Hyperinsulinemia) 01/2022 - 10/2019
2	Fatty Liver 01/2022 - 10/2019
2	Embolism (Embolus) 05/2021 - 10/2016
2	Sick Sinus Syndrome 01/2021 - 01/2013
2	Dextrocardia 01/2021 - 05/2012
2	Aortic Dissection 01/2019 - 08/2013
2	Infarction (Infarctions) 01/2019 - 04/2017
2	Obesity 01/2018 - 01/2018
2	Necrosis 01/2018 - 01/2018
2	Atrial Heart Septal Defects (Atrial Septal Defect) 01/2018 - 01/2015
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2018 - 01/2015
2	Transient Ischemic Attack 10/2016 - 01/2016
1	Bundle-Branch Block (Fascicular Block) 01/2024
1	Glycogen Storage Disease Type IIb 01/2023
1	Sarcoidosis (Schaumann Disease) 01/2023
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2023
1	Cardiomyopathies (Cardiomyopathy) 01/2023
1	Muscular Diseases (Myopathy) 01/2023
1	Intellectual Disability (Idiocy) 01/2023
1	Neointima 11/2022
1	Wounds and Injuries (Trauma) 11/2022
1	Disseminated Intravascular Coagulation 01/2022
1	Fever (Fevers) 01/2022
1	Multiple Organ Failure (MODS) 01/2022
1	Myocarditis (Carditis) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022

Drug/Important Bio-Agent (IBA)

7	Anti-Arrhythmia AgentsIBA 01/2021 - 01/2007
6	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 01/2016
6	AnticoagulantsIBA 01/2022 - 01/2016
5	Biomarkers (Surrogate Marker)IBA 10/2023 - 12/2019
4	HomocysteineIBA 01/2018 - 01/2017
3	LipidsIBA 04/2022 - 06/2018
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 10/2016
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2019
2	omega-Chloroacetophenone (Mace)IBA 01/2022 - 09/2018
2	CholesterolIBA 01/2022 - 10/2019
2	Dabigatran FDA Link 11/2021 - 10/2018
2	Interleukin-18 (Interleukin 18)IBA 10/2020 - 01/2014
2	MicroRNAs (MicroRNA)IBA 12/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2018
2	AntioxidantsIBA 01/2018 - 08/2014
2	C-Reactive ProteinIBA 10/2015 - 08/2013
2	Chemokine CCL5IBA 01/2015 - 01/2014
2	S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA 05/2012 - 12/2010
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2023
1	Ethanol (Ethyl Alcohol)IBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	Lysosomal Membrane ProteinsIBA 01/2023
1	AntralIBA 01/2023
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 11/2022
1	Indicators and Reagents (Reagents)IBA 11/2022
1	Polo-Like Kinase 1IBA 11/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2022
1	myotubularinIBA 11/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2022
1	LDL CholesterolIBA 04/2022
1	oxidized low density lipoproteinIBA 04/2022
1	ubiquitin-aldehydeIBA 01/2022
1	APTIBA 01/2022
1	Deubiquitinating EnzymesIBA 01/2022
1	Mineralocorticoid Receptor AntagonistsIBA 01/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022
1	Growth Differentiation Factor 15IBA 01/2022
1	Angiotensin Receptor AntagonistsIBA 01/2022
1	idarucizumabIBA 11/2021

Therapy/Procedure

57	Catheter Ablation 01/2024 - 01/2009
12	Therapeutics 10/2023 - 01/2016
5	Catheters 10/2023 - 11/2007
3	Radiofrequency Ablation 01/2018 - 03/2014
2	Autologous Blood Transfusion 01/2022 - 04/2010
2	Drug Therapy (Chemotherapy) 10/2021 - 11/2013
2	Electric Countershock (Cardioversion) 08/2021 - 06/2012
2	Percutaneous Coronary Intervention 02/2014 - 08/2007
1	Length of Stay 01/2022
1	Perioperative Period 11/2021